Biocon moves up to sixth spot in Global Biotech Employers ranking

It continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list, since its debut in 2012

Kiran Mazumdar-Shaw, CMD, Biocon
Kiran Mazumdar-Shaw, CMD, Biocon
Press Trust of India Bengaluru
2 min read Last Updated : Oct 28 2019 | 6:18 PM IST

Bengaluru-headquartered biopharmaceuticals company Biocon Ltd has moved up to sixth spot in the Top 10 Global Biotech Employers ranking for 2019.

It continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list, since its debut in 2012.

Ranked at number six among global pharma and biotech companies in 2019, Biocon has moved up from number seven in 2018 and number nine in 2017.

Biocon said in a statement it has been consistently recognised for three key attributes: "Innovative leader in the industry, 'is socially responsible' and leadership makes changes needed."

The ranking is a result of the 2019 Science Careers Top Employers global survey conducted by the US-based Science magazine to determine which companies in the biotech and pharmaceutical industry have the best reputations as employers globally.

Kiran Mazumdar Shaw, CMD, Biocon said: "We have consciously created a culture that encourages ideation, experimentation and collaboration to address unmet patient needs."

Biocon was ahead of leading global pharma companies like Novozymes, Roche, Eli Lilly, Abbott, Novartis, Pfizer etc. in the 2019 rankings.

The Top 5 global players in this year's list are Alnylam, Regeneron, Incyte, Merck KGaA and Spark therapeutics.

Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including 'innovative leader in the industry,' 'treating employees with respect,' 'is socially responsible,' 'work culture values aligned' and 'leadership makes changes needed,' it was stated.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Bioconbiotech

First Published: Oct 28 2019 | 5:40 PM IST

Next Story